Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer
Abstract Background: Bacillus Calmette-Guerin (BCG) is the most effective intravesical therapy for non-muscle invasive bladder cancer (NMIBC), but patients can fail or supply shortages can develop. For BCG failures, radical cystectomy is recommended. However, in patients who desire bladder preservat...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
SAGE Publishing
2015-04-01
|
| Seria: | Bladder Cancer |
| Dostęp online: | https://doi.org/10.3233/BLC-150008 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
